Nathalie A. Johnson

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

Ryan D. Morin, Nathalie A. Johnson, Tesa Severson et al. · Nature Genetics · 2010 · 1.6K citations · Full text

Life Sciences, Genetics, Oncology +16

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

R. Eric Davis, Vu N. Ngo, Georg Lenz et al. · Nature · 2010 · 1.6K citations · Full text

Medicine, Hematology, Oncology +14

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Ryan D. Morin, María Méndez-Lago, Andrew J. Mungall et al. · Nature · 2011 · 1.6K citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

Robert Chen, Pier Luigi Zinzani, Michelle A. Fanale et al. · Journal of Clinical Oncology · 2017 · 985 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Nathalie A. Johnson, Graham W. Slack, Kerry J. Savage et al. · Journal of Clinical Oncology · 2012 · 973 citations

Medicine, Cancer Biology, Oncology +13